Across TCGA pan-cancer cohorts, HSPE1 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated HSPE1 data layer compared with 28 for mass-spec protein and 2 for mutation status.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher HSPE1 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated HSPE1 expression acts as an unfavorable survival marker, although some lineages such as COAD and PDAC show a favorable association.
COAD, PDAC, and LUAD are the cancer types where HSPE1 mass-spec protein most reproducibly stratifies survival.